Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection.

MLA

Hildesheim, Allan, et al. “Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection.” JAMA: Journal of the American Medical Association, vol. 298, no. 7, Aug. 2007, pp. 743–53. EBSCOhost, https://doi.org/10.1001/jama.298.7.743.

APA

Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., Jimenez, S. E., & Lowy, D. R. (2007). Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection. JAMA: Journal of the American Medical Association, 298(7), 743–753. https://doi.org/10.1001/jama.298.7.743

Chicago

Hildesheim, Allan, Rolando Herrero, Sholom Wacholder, Ana C. Rodriguez, Diane Solomon, M. Concepcion Bratti, John T. Schiller, et al. 2007. “Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection.” JAMA: Journal of the American Medical Association 298 (7): 743–53. doi:10.1001/jama.298.7.743.